8-methoxyquinolone

Moxifloxacin hydrochloride (BAY12-8039 HCl) is a fourth generation fluoroquinolone with expanded activity against gram-positive bacteria as well as atypical pathogens. Moxifloxacin has been linked to mild ALT elevations during therapy and to rare instances of idiosyncratic acute liver injury with symptoms and jaundice.

Decarboxy Moxifloxacin is a decarboxylated compound of moxifloxacin. Moxifloxacin is an oral active 8-methoxyquinolone antibiotic used in acute bacterial sinusitis, chronic bronchitis, acute bacterial deterioration, and community-acquired pneumonia.

Tetranor-Misoprostol is a derivative of Moxifloxacin and an active metabolite of the prostaglandin E1 analogue. Moxifloxacin is an 8-methoxyquinolone antibacterial antibiotic used in the study of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and pneumonia.

Moxifloxacin-13C,d3 hydrochloride (BAY 12-8039-13C,d3) is the 13C labeled variant of Moxifloxacin. Moxifloxacin is an orally effective 8-methoxyquinolone compound with antibacterial properties, used in the study of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and infectious pneumonia.

Moxifloxacin N-sulfate disodium is an anionic sulfonate derivative of Moxifloxacin. Moxifloxacin is an 8-methoxyquinolone antibacterial antibiotic, used in studies of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and infectious pneumonia.

(Rac)-Moxifloxacin ((Rac)-BAY 12-8039 free base) is an isomer of Moxifloxacin Hydrochloride. Moxifloxacin Hydrochloride (BAY 12-8039) is an orally effective 8-methoxyquinolone antibacterial agent used in studies on acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and infectious pneumonia.